Benefit-sharing from DSI rests on the provider country's national framework. Where it requires bilateral benefit-sharing for DSI, those terms apply. Where it gives effect to the CBD multilateral mechanism, users of its publicly available DSI should share benefits through it: all users non-monetary benefits, as appropriate, and commercial users above set size thresholds also monetary contributions to the Cali Fund. Where it is silent on DSI, the position is not yet settled: check with the country's competent national authority, through the ABS service. Any terms agreed when the genetic resources were accessed still apply. Access and benefit-sharing questions are handled by the ABS service, not by the DataBank. Learn more →
Light/fluorescence microscopy of cells & tissues, and electron/cryo-EM imaging of macromolecular structures — a metadata catalog with a durable link back to the source archive, not a hosted image gallery. These are primary research datasets (often multi-GB to multi-TB), so this platform never downloads or stores the underlying imaging data itself. Datasets already in either source archive are ingested via accession paste/CSV at /mirroring by a Continental Admin (no automated harvesting — neither source archive supports geography-filterable search); a dataset not yet in either archive can instead be submitted directly below by any node operator, for Continental Admin review. Either way, whoever submits an accession or a self-submitted dataset is the one asserting African origin — this platform does not verify it.
Chronic Pseudomonas aeruginosa lung infection is a major cause of morbidity and mortality in people with lung disease. Once established, infection is rarely eradicated and often persists despite prolonged antimicrobial therapy, but the mechanisms that support persistence in the human lung remain poorly understood. To define how P. aeruginosa occupies and adapts to diseased lung tissue, we applied host–pathogen spatial transcriptomics to explanted and resected lungs from people with Cystic Fibrosis (CF) and chronic obstructive pulmonary disease (COPD), mapping bacterial niches and transcriptional states in situ.
Two antagonistic response regulators control Pseudomonas aeruginosa polarization during mechanotaxis
BioImage Archive:S-BSST1007 · Marco Kühn (École Polytechnique Fédérale de Lausanne) · Pseudomonas muyukensis
Source data for figures corresponding to the study: Two antagonistic response regulators control Pseudomonas aeruginosa polarization during mechanotaxis. DOI: https://doi.org/10.15252/embj.2022112165
Topical Formulation of Repurposed FDA-Approved Compounds Inhibits Pseudomonas aeruginosa ExoU and Improves Corneal Infection Outcome
BioImage Archive:S-BIAD2625 · (University of Liverpool) · Pseudomonas muyukensis
Showing 5441–5450 of 8036
Microbial keratitis, infection of the cornea, cause by ExotoxinU (ExoU) strains of Pseudomonas aeruginosa have a poor clinical outcome and response to antimicrobials. ExoU, a phospholipase, is secreted directly into host cells, causing their lysis. A screen of 3,034 FDA-approved compounds identified zinc pyrithione (Zp), bismuth subcitrate (Bis), and polymyxin B (Pol) as lead inhibitors of ExoU selectively inhibiting it without affecting human PLA2s or bacterial viability. The compounds have distinct inhibitory mechanisms: Zp disrupted ExoU oligomerization and protein stability; Bis impaired phosphatidylinositol 4,5-bisphosphate-dependent membrane association; Pol directly inhibited catalysis via its lipid-peptide architecture. Compound combinations enhanced ExoU inhibition in vitro to nanomolar concentrations. In mammalian cells, Bis and Pol promoted lysosomal trafficking and degradation of ExoU. Using a high-throughput microscopy platform, we screened 53 P. aeruginosa keratitis isolates, confirming broad efficacy of these inhibitors in exoU⁺ strains. Therapeutic efficacy was evaluated in ex vivo porcine corneas, Galleria mellonella, and in vivo mouse keratitis models. Topical delivery of ExoU inhibitors, particularly in combination, significantly reduced corneal opacity, ulceration, and stromal damage in porcine corneas without affecting bacterial load. In Galleria, compound combinations significantly maintained larval health, improved larval survival and delayed mortality. In a mouse eye infection model, combinatorial treatment reduced disease severity and preserved tissue viability without altering bacterial burden. These findings validate ExoU as a druggable virulence factor and support the repurposing of these compounds as an anti-virulence strategy for the treatment of P. aeruginosa infections in humans and veterinary medicine.
Antagonistic second messenger signalling coordinates Pseudomonas aeruginosa surface colonization and virulence
BioImage Archive:S-BIAD3989 · (University of Basel) · Pseudomonas sp.
Efficient colonisation of host tissue surfaces is a prerequisite for bacterial infection. In the human pathogen Pseudomonas aeruginosa, the second messengers cAMP and c-di-GMP regulate surface behaviours and virulence, but how these pathways are coordinated during tissue infection has remained unclear. Here we demonstrate that cAMP and c-di-GMP establish mutually exclusive signalling states at the single-cell level, generating distinct subpopulations of motile and surface-attached cells through pathway-specific control of type IV pili (T4P). Initial surface contact triggers an increase in c-di-GMP, activating FimW and driving stable attachment via bipolar T4P formation. This state is progressively replaced by cAMP, which inactivates FimW-dependent attachment and induces FimX-mediated T4P polarisation, surface motility and virulence activation. The resulting signalling transition enforces coexisting subpopulations, with attached cells gradually displaced by spreading cells. Using a human airway tissue model, we show that both T4P-mediated adhesion and twitching motility are required for invasion and tissue damage. Based on this, we propose that reciprocal cAMP-c-di-GMP signalling coordinates complementary T4P functions to optimise P. aeruginosa surface colonisation and infection.
Mycosis fungoides (MF), a type of cutaneous T-cell lymphoma, presents with diverse clinical manifestations and lacks definitive early diagnostic markers. This study applies CD30-positive large cell transformation as a model to identify tumor cell-specific early diagnostic indicators in MF by comparing malignant T cells (MT) with reactive T cells (RT). Utilizing Deep Visual Proteomics (DVP) technique, including immunohistochemistry, single-cell laser microdissection, and mass spectrometry-based proteomics, we elucidated molecular differences associated with disease progression and epidermotropism. Key findings revealed significant upregulation of cell cycle-related proteins (MCM2-7, PCNA) and chromatin remodeling factors in MT cells. Conversely, downregulated proteins (CMA1, KREMEN2) in MT cells were linked to reduced inflammatory response and cytoskeletal changes. Longitudinal analysis pinpointed proteins and pathways upregulated in advanced-stage MF, particularly those involved in DNA replication, chromatin modification, and stress response. Spatial analysis identified proteins related to cell adhesion and cytoskeletal dynamics contributing to epidermotropism. Our findings uncover novel tumor-specific biomarkers and critical molecular pathways involved in MF progression. The upregulation of proteins associated with cell proliferation, chromatin remodeling, and epidermal adhesion provides promising targets for early diagnosis and therapeutic intervention. This study enhances our understanding of MF pathogenesis and offers insights for developing improved diagnostic and treatment strategies.
Antagonistic second messenger signalling coordinates Pseudomonas aeruginosa surface colonization and virulence
BioImage Archive:S-BIAD3989 · (University of Basel) · Pseudomonas muyukensis
Efficient colonisation of host tissue surfaces is a prerequisite for bacterial infection. In the human pathogen Pseudomonas aeruginosa, the second messengers cAMP and c-di-GMP regulate surface behaviours and virulence, but how these pathways are coordinated during tissue infection has remained unclear. Here we demonstrate that cAMP and c-di-GMP establish mutually exclusive signalling states at the single-cell level, generating distinct subpopulations of motile and surface-attached cells through pathway-specific control of type IV pili (T4P). Initial surface contact triggers an increase in c-di-GMP, activating FimW and driving stable attachment via bipolar T4P formation. This state is progressively replaced by cAMP, which inactivates FimW-dependent attachment and induces FimX-mediated T4P polarisation, surface motility and virulence activation. The resulting signalling transition enforces coexisting subpopulations, with attached cells gradually displaced by spreading cells. Using a human airway tissue model, we show that both T4P-mediated adhesion and twitching motility are required for invasion and tissue damage. Based on this, we propose that reciprocal cAMP-c-di-GMP signalling coordinates complementary T4P functions to optimise P. aeruginosa surface colonisation and infection.